首页> 外文期刊>International journal of monetary economics and finance >Generic drug in Indonesia: why physicians and pharmacists matters
【24h】

Generic drug in Indonesia: why physicians and pharmacists matters

机译:印度尼西亚的仿制药:医师和药剂师为何重要

获取原文
获取原文并翻译 | 示例
           

摘要

Since 2014, Indonesia began imposing the National Health Insurance program. One of the goals of implementing the program is to increase the use of generic drugs. This action was done to respond the low use of generic drugs, which is around 11%, in 2011 (World Bank, 2008). Therefore, this study tried to examine the factors that influence the purchase intention of generic drugs based on the information from physicians and pharmacists. Also the overall information risk with experience was used as moderating variable. The research sample for this includes 400 respondents. The questionnaires were distributed from September 2014 until December 2015. The questionnaire distribution takes a relatively long time due to the very small number of generic drug users were available. The result shows that physician information have the biggest effect on the purchase intention of generic drugs, and that experience has a significant effect as moderating variable.
机译:自2014年以来,印度尼西亚开始实施国民健康保险计划。实施该计划的目标之一是增加仿制药的使用。采取这一行动是为了应对2011年仿制药的低使用率,这一比例约为11%(世界银行,2008年)。因此,本研究试图根据医师和药剂师的信息来研究影响仿制药购买意向的因素。同样,将具有经验的总体信息风险用作调节变量。为此的研究样本包括400名受访者。问卷于2014年9月至2015年12月之间分发。由于可用的非专利药数量很少,因此问卷分发时间相对较长。结果表明,医师信息对仿制药的购买意图影响最大,而经验作为调节变量具有显着影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号